Fatty Acid Oxidation Disorder
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism
Systemic Biomarkers of Brain Injury From Hyperammonemia
A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders
Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders
Market Research - Acceptability Study for New MCT Fat Products
Market Research - Acceptability Study for a Range of MCT Products